BackRapid Dose Therapeutics Overview

Rapid Dose Therapeutics Other Current Assets

Rapid Dose Therapeutics's other current assets is $36K.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$35566.00
↓ 65.63% YoYΔ $-67915.00 vs prior year quarter

Peer average / median

Loading

Rapid Dose Therapeutics Other Current Assets History

Loading

Rapid Dose Therapeutics vs. peers: Other Current Assets Comparison

Loading

Rapid Dose Therapeutics Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Rapid Dose Therapeutics (RDTCF) FAQ

Rapid Dose Therapeutics posts a other current assets of $36K as of August 2026. That compares with $100K in the prior-year period — down 65.6% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Rapid Dose Therapeutics's other current assets was $100K. The latest reading is $36K — a 65.6% year-over-year decrease (period ending August 2026). Use the history and growth charts on this page for a longer lookback.

Other Current Assets is one piece of Rapid Dose Therapeutics's financial statement story. At $36K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for RDTCF's other current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Rapid Dose Therapeutics's other metric pages and overview cover the third.

Judging Rapid Dose Therapeutics against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in other current assets easier to interpret. Start with $36K here, then scan peer and history charts to see if the gap is persistent.